Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laosixietai in advanced NSCLC after 2nd/3rd line failure
CTR20131722Phase 2Active
- Sponsor
- China Medical System Holdings Limited
- Start
- May 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of laosixietai in non-small cell lung cancer (NSCLC), sponsored by China Medical System Holdings Limited. Started May 2014; status: active.
02
Drugs
laosixietai
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20131722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131722.